| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/18/2009 | CN101370830A Human monoclonal antibodies to CD70 |
| 02/18/2009 | CN101370805A Novel pyridine derivatives |
| 02/18/2009 | CN101370796A Thiazoles as 11 beta-HSD1 inhibitors |
| 02/18/2009 | CN101370783A Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on their base, their use, preventive measures and treatment |
| 02/18/2009 | CN101370496A Novel thiophene derivatives as S1P1/EDG1 receptor agonists |
| 02/18/2009 | CN101370396A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101368152A Preparation method for cordyceps sinensis solid haelth-care medicinal wine |
| 02/18/2009 | CN101367882A Sulfating numerator modification method of epimedium brevicornum polysaccharide |
| 02/18/2009 | CN101367881A High-efficiency preparation method for glossy ganoderma polysaccharide |
| 02/18/2009 | CN101367877A Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions |
| 02/18/2009 | CN101367871A Snake venom protein component of ahylysantinfarctase at southern Anhui Province, extraction method and uses thereof |
| 02/18/2009 | CN101367866A Crucial active peptide segment with immunosuppression function in early pregnancy factor |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/18/2009 | CN101367716A Carbon shell bacterium polyketone, preparation and uses thereof |
| 02/18/2009 | CN101366948A Sodium cholate coated liposoluble medicament metacortandracin intercalation hydrotalcite and preparation method thereof |
| 02/18/2009 | CN101366928A Pure natural health preserving plaster and preparation method thereof |
| 02/18/2009 | CN101366921A Novel functional Chinese medicinal composition ¡®protection¡¯ particle for reinforcing life vitality |
| 02/18/2009 | CN101366914A Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method |
| 02/18/2009 | CN101366857A Baicaoyiqiang Chinese medicinal composition and preparation method thereof |
| 02/18/2009 | CN101366847A Medicament for treating atrophic thyroiditis |
| 02/18/2009 | CN101366831A Rhubarb polyoses, preparation method, medicament composition and uses |
| 02/18/2009 | CN101366814A Novel medicament for treating systematic lupus erythematosus |
| 02/18/2009 | CN101366715A Rapamycin composition and preparation thereof |
| 02/18/2009 | CN101366698A Biogastrone acid prosome liposome with long circulation function and preparation method thereof |
| 02/18/2009 | CN101366588A Health care massage pillow |
| 02/18/2009 | CN101366510A Infusion beverage for preventing common cold |
| 02/18/2009 | CN100462438C Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 02/18/2009 | CN100462437C A fungal immuromodulatory protein produced by microorganisme and uses there of |
| 02/18/2009 | CN100462354C Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 02/18/2009 | CN100462352C Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/17/2009 | US7491825 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 02/17/2009 | US7491803 Atopic dermatitis, airway inflammation, airway hyperresponsiveness, or asthma; cytokine biosynthesis inhibition; diagnostic kits |
| 02/17/2009 | US7491801 Identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 02/17/2009 | US7491746 Treating cell proliferation disorder, anticancer agents |
| 02/17/2009 | US7491740 Isoxazoline compounds having MIF antagonist activity |
| 02/17/2009 | US7491739 TNF-α production inhibitors |
| 02/17/2009 | US7491734 psychotic and intellectual impairment disorders; Alzheimer's disease, cognitive or attention disorders, antidepressant, anxiolytic agent; ,smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's syndrome, and Parkinson's disease |
| 02/17/2009 | US7491730 Compositions useful as inhibitors of GSK-3 |
| 02/17/2009 | US7491722 Pyridazin-3(2H)-one derivatives |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/17/2009 | US7491516 Dual specificity antibodies and methods of making and using |
| 02/17/2009 | US7491514 High specificity antibodies with reduce immunogenicity; evaluative and diagnostic tools; immunotherapy |
| 02/17/2009 | US7491392 An isolated IL-1 beta binding molecule comprising a heavy chain variable domain; treatment of an IL-1 mediated disease or disorder, e.g. osteoarthritis, osteroporosis and other inflammatory arthritis |
| 02/17/2009 | US7491388 human fibroblasts are contacted with allogeneic T lymphocytes, in vitro, fibroblasts suppressed an ongoing mixed lymphocyte reaction co-culturing cells from different individuals results in a T cell response, manifested by activation and proliferation of the T cells |
| 02/17/2009 | US7491047 Delivery of antihistamines through an inhalation route |
| 02/17/2009 | CA2400217C Pteridine compounds for the treatment of psoriasis |
| 02/17/2009 | CA2383555C 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/17/2009 | CA2231404C Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/12/2009 | WO2009020534A2 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 02/12/2009 | WO2009020119A1 Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor |
| 02/12/2009 | WO2009020094A1 Antibody modified with hydrophobic molecule |
| 02/12/2009 | WO2009020093A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | WO2009019317A1 Composition and therapeutic anti-tumour vaccine |
| 02/12/2009 | WO2008129148A3 Use of lactobacillus casei for increasing the protection provided by the influenza vaccine |
| 02/12/2009 | WO2008071605A3 Methods of treating inflammatory diseases |
| 02/12/2009 | WO2008028963A3 Calreticulin for its use as a medication for the treatment of cancer in a mammal |
| 02/12/2009 | US20090043076 Modified interferon beta with reduced immunogenicity |
| 02/12/2009 | US20090042959 Compounds having immunomodulator activity |
| 02/12/2009 | US20090042955 Bicyclic sphingosine 1-phosphate analogs |
| 02/12/2009 | US20090042954 Trans-2-(4-(5-(4-(2-methylpropyl)phenyl)-1,2,4-oxadiazol-3-yl)phenyl)-4-pyrrolidineacetic acid; have immunosuppressive, anti-inflammatory and hemostatic activities by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity |
| 02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 02/12/2009 | US20090042911 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042885 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 02/12/2009 | US20090042884 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 6-(indol-4-yl)-4-(morpholin-4-yl)-2-[(2-(pyridin-2-yl)ethylamino]pyrimidine |
| 02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
| 02/12/2009 | US20090042831 Use of 5'-methylthioadenosine (mta) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection |
| 02/12/2009 | US20090042818 Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |
| 02/12/2009 | US20090042807 By reducing macrophage NO production through administration of one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides; inhibition of neucrosis factor kappa Beta mediated inflammatory cytokine release |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042792 18 human secreted proteins |
| 02/12/2009 | US20090042785 Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (Ctla-4) |
| 02/12/2009 | US20090042768 Purine derivatives and their use for treatment of autoimmune diseases |
| 02/12/2009 | US20090042225 Method for selecting therapeutic agents for cancer treatment |
| 02/12/2009 | US20090042221 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents; drug screening |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041852 Dry powder compositions and systems for poultry vaccination |
| 02/12/2009 | US20090041810 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 02/12/2009 | US20090041809 Double-stranded locked nucleic acid compositions |
| 02/12/2009 | US20090041798 Leishmania sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis |
| 02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
| 02/12/2009 | US20090041792 Dendritic cells, uses therefor, and vaccines and methods comprising the same |
| 02/12/2009 | US20090041786 e.g. 5-Fluoro-N4-(3-hydroxyphenyl)-N2-[4-(N-methyl)aminosulfonyl-3-methoxyphenyl]-2,4-pyrimidinediamine; tyrosine (JAK) kinases inhibitor; interleukin and tumor necrosis factor ligand; transplant rejection; T-cell mediated autoimmune disease |
| 02/12/2009 | US20090041775 Use of CD25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
| 02/12/2009 | US20090041769 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 02/12/2009 | US20090041758 Modified binding molecules comprising connecting peptides |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | US20090041739 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | CA2695991A1 Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor |
| 02/12/2009 | CA2695478A1 Composition and therapeutic anti-tumour vaccine |
| 02/12/2009 | CA2695365A1 Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2021372A2 Compositions and methods for modulating immune responses |
| 02/11/2009 | EP2021350A1 Phosphorylated a2a receptor agonists |
| 02/11/2009 | EP2021321A2 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof |
| 02/11/2009 | EP2021013A2 Tracheal cytotoxin (tct) and related compounds for suppressing immune responses |
| 02/11/2009 | EP2021003A2 Imidazoazephinone compounds |